Promore: First patient included in the LL-37 HEAL study
Research Note
2018-10-01
09:35
Promore announced this morning that the first patient has been enrolled in their phase IIb HEAL study with LL-37 for the treatment of venous leg ulcers.
MS
Mathias Spinnars
Disclosures and disclaimers